FN Media Group Presents USA News Group News Commentary

VANCOUVER, British Columbia, March 24, 2023 /PRNewswire/ -- USA News Group - Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs being labeled as landmark in nature and giving hope to families dealing with a fateful diagnosis. According to the American Cancer Society in 2022, the 5-year relative survival rate for localized breast cancer, cancer that has not spread outside the breast, is 99%, and for those whose cancer has spread outside the breast to nearby structures or lymph nodes, the survival rate is 86%. Over the last year, the biotech sector has increased its efforts and delivered very optimistic data from such groups as Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), CytomX Therapeutics, Inc. (NASDAQ: CTMX), BriaCell Therapeutics (NASDAQ: BCTX) (NASDAQ: BCTXW) (TSX: BCT), Relay Therapeutics (NASDAQ: RLAY), and Hologic, Inc. (NASDAQ: HOLX).